Population pharmacokinetic‐pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease
出版年份 2022 全文链接
标题
Population pharmacokinetic‐pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease
作者
关键词
-
出版物
CPT-Pharmacometrics & Systems Pharmacology
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-09-27
DOI
10.1002/psp4.12862
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis
- (2021) Tim West et al. Molecular Neurodegeneration
- A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
- (2021) Chad J. Swanson et al. Alzheimers Research & Therapy
- Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
- (2021) Bruno Dubois et al. LANCET NEUROLOGY
- Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
- (2021) Xue-Ning Shen et al. Translational Psychiatry
- Population pharmacokinetics and standard uptake value ratio of aducanumab, an amyloid plaque–removing agent, in patients with Alzheimer’s disease
- (2021) Kumar Kandadi Muralidharan et al. CPT-Pharmacometrics & Systems Pharmacology
- Total Aβ42/Aβ40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis
- (2020) James D. Doecke et al. NEUROLOGY
- The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease
- (2020) Christoforos Hadjichrysanthou et al. Alzheimers Research & Therapy
- Evaluation of Covariate Effects on Pharmacokinetics of Monoclonal Antibodies in Oncology
- (2019) Gaurav Bajaj et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
- (2019) Suzanne E. Schindler et al. NEUROLOGY
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- (2019) Sebastian Palmqvist et al. EMBO Molecular Medicine
- A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers
- (2019) Agnès Portron et al. CLINICAL THERAPEUTICS
- Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
- (2018) Niklas Mattsson et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Specific Uptake of an Amyloid-β Protofibril-Binding Antibody-Tracer in AβPP Transgenic Mouse Brain
- (2018) Kristina Magnusson et al. JOURNAL OF ALZHEIMERS DISEASE
- The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-β Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice
- (2018) Stina Tucker et al. JOURNAL OF ALZHEIMERS DISEASE
- Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics
- (2016) Katherine L. Gill et al. CLINICAL PHARMACOKINETICS
- Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
- (2016) Veronika Logovinsky et al. Alzheimers Research & Therapy
- Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts
- (2015) Susan M. Resnick et al. NEUROBIOLOGY OF AGING
- Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides—Harmonized Terminology and Tactical Recommendations
- (2014) G. Shankar et al. AAPS Journal
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Large Aggregates Are the Major Soluble Aβ Species in AD Brain Fractionated with Density Gradient Ultracentrifugation
- (2012) Dag Sehlin et al. PLoS One
- Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
- (2011) Martin Bergstrand et al. AAPS Journal
- Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease
- (2011) Adam S. Fleisher ARCHIVES OF NEUROLOGY
- Predictive value of APOE- 4 allele for progression from MCI to AD-type dementia: a meta-analysis
- (2011) L. S. Elias-Sonnenschein et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Ron J. Keizer et al. CLINICAL PHARMACOKINETICS
- Heavy-Chain Complementarity-Determining Regions Determine Conformation Selectivity of Anti-Aβ Antibodies
- (2010) Dag Sehlin et al. Neurodegenerative Diseases
- Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic–pharmacodynamic modeling of biologics
- (2009) Leonid Gibiansky et al. Expert Opinion on Drug Metabolism & Toxicology
- An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
- (2009) Anna Lord et al. NEUROBIOLOGY OF DISEASE
- Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms
- (2008) Hélène Amieva et al. ANNALS OF NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started